Condensed Balance Sheets (Current Period Unaudited) - USD ($)	Sep. 30, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 25,516,054	$ 38,628,876
Accounts Receivable	34,852	0
Prepaid expenses and other	757,279	511,348
Total current assets	26,308,185	39,140,224
Property and equipment, net	29,109	48,608
Other assets:
Security deposits	21,818	8,691
Supplies	2,904,617	3,022,403
Intellectual property, net	682,097	642,360
Total other assets	3,608,532	3,673,454
Total assets	29,945,826	42,862,286
Current liabilities:
Accounts payables	683,871	973,195
Other current liabilities	1,773,440	612,100
Total current liabilities	2,457,311	1,585,295
Stockholders’ equity:
Preferred stock $0.001 par value: 10,000,000 shares authorized; no shares issued and outstanding	0	0
Common stock $0.001 par value: 200,000,000 shares authorized; 48,020,324 and 47,874,708 shares issued and outstanding at September 30, 2022, and December 31, 2021, respectively	48,020	47,874
Additional paid-in capital	122,432,935	119,246,970
Accumulated deficit	(94,992,440)	(78,017,853)
Total stockholders’ equity	27,488,515	41,276,991
Total liabilities and stockholders’ equity	$ 29,945,826	$ 42,862,286

The amount of research and development assets classified as noncurrent.

No definition available.

Name:	gnpx_ResearchAndDevelopmentAssetsNoncurrent
Namespace Prefix:	gnpx_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.